Distribution of adjuvant MF59 and antigen gD2 after intramuscular injection in mice

By Dupuis M.   McDonald D.M.   Ott G.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 434-439

Elsevier

Access to resources Recommend Favorite

The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice

By Barchfeld G.L.   Hessler A.L.   Chen M.   Pizza M.   Rappuoli R.   Van Nest G.A.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 695-704

Elsevier

Access to resources Recommend Favorite

Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1

By O'Hagan D.T.   Ugozzoli M.   Barackman J.   Singh M.   Kazzaz J.   Higgins K.   Vancott T.C.   Ott G.  

Vaccine, Vol. 18, Iss. 17, 2000-03 ,pp. : 1793-1801

Elsevier

Access to resources Recommend Favorite

The comparison of the effect of LTR72 and MF59 adjuvants on mouse humoral response to intranasal immunisation with human papillomavirus type 6b (HPV-6b) virus-like particles

By Greer C.E.   Petracca R.   Buonamassa D.T.   Di Tommaso A.   Gervase B.   Reeve R.L.   Ugozzoli M.   Van Nest G.   De Magistris M.T.   Bensi G.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1008-1012

Elsevier

Access to resources Recommend Favorite

Effect of route of vaccination with vaccinia virus expressing HSV-2 glycoprotein D on protection from genital HSV-2 infection

By Bernstein D.I.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1351-1358

Elsevier

Access to resources Recommend Favorite